Excellent safety, evidence of activity for beta-alethine in immunocompetent lymphoma patients Dec. 13, 2001
Early data from NHL patients treated with CpG-7909 indicate good safety, immunostimulatory effects Dec. 13, 2001
Immunomodulatory thalidomide derivative as a potential new therapeutic option for multiple myeloma Dec. 11, 2001
RSS